Shenzhen FDA: More Than 75% Of Imported Cancer Drugs Fake
This article was originally published in PharmAsia News
Executive Summary
China’s Shenzhen FDA has warned that more than 75% of cancer drugs bought from overseas via agencies were fake or poor quality.